Globe Life Inc. (NYSE:GL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Key Points

• Analysts maintain a “Moderate Buy” consensus on Globe Life, with eight buy ratings, two holds and one strong-buy rating. The average 12-month price target is $191.67, above the reported share price of $171.07.
• Globe Life’s latest quarterly earnings came in slightly below expectations at $3.61 per share, while revenue rose 8% year over year to $1.60 billion. The company issued fiscal 2026 EPS guidance of $15.55–$15.95.
• The board authorized a $2.5 billion share-repurchase program, potentially covering up to 17.7% of outstanding shares, alongside a quarterly dividend of $0.33 per share. Meanwhile, company insiders sold approximately $27.2 million of stock over the past quarter.

Globe Life Inc. (NYSE:GL - Get Free Report) has received an average rating of "Moderate Buy" from the eleven ratings firms that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $191.6667.

GL has been the subject of a number of recent analyst reports. Keefe, Bruyette & Woods decreased their price target on shares of Globe Life from $192.00 to $190.00 and set an "outperform" rating for the company in a report on Friday, July 24th. Piper Sandler boosted their price objective on Globe Life from $175.00 to $200.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 15th. JPMorgan Chase & Co. raised their target price on Globe Life from $181.00 to $201.00 and gave the company an "overweight" rating in a report on Tuesday, July 21st. TD Cowen lifted their price target on Globe Life from $215.00 to $225.00 and gave the stock a "buy" rating in a research report on Wednesday, July 22nd. Finally, Jefferies Financial Group upped their price target on Globe Life from $147.00 to $166.00 and gave the stock a "hold" rating in a report on Friday, July 10th.

Insider Activity

In other Globe Life news, CFO Thomas Peter Kalmbach sold 25,650 shares of the firm's stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total value of $4,580,577.00. Following the sale, the chief financial officer directly owned 50,568 shares in the company, valued at $9,030,433.44. This trade represents a 33.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO James Matthew Darden sold 50,000 shares of the business's stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the transaction, the chief executive officer owned 58,451 shares in the company, valued at approximately $10,663,215.93. The trade was a 46.10% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 151,908 shares of company stock worth $27,239,981. Corporate insiders own 2.11% of the company's stock.

Institutional Investors Weigh In On Globe Life

Several hedge funds have recently made changes to their positions in GL. Jupiter Asset Management Ltd. acquired a new stake in Globe Life during the fourth quarter worth $2,073,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Globe Life by 34,786.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company's stock valued at $123,345,000 after buying an additional 879,391 shares in the last quarter. Strs Ohio raised its stake in shares of Globe Life by 213.7% in the 4th quarter. Strs Ohio now owns 21,907 shares of the company's stock valued at $3,064,000 after buying an additional 14,924 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Globe Life by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company's stock valued at $1,411,311,000 after buying an additional 86,349 shares in the last quarter. Finally, Norges Bank bought a new position in shares of Globe Life during the 4th quarter worth about $155,617,000. Institutional investors own 81.61% of the company's stock.

Globe Life Trading Up 0.3%

NYSE:GL opened at $171.07 on Friday. The company's 50 day moving average is $178.36 and its 200-day moving average is $158.52. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life has a 12 month low of $127.85 and a 12 month high of $191.55. The firm has a market cap of $13.15 billion, a price-to-earnings ratio of 11.36 and a beta of 0.48.

Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a return on equity of 20.52% and a net margin of 19.58%.Globe Life's quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the company posted $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities analysts anticipate that Globe Life will post 15.71 EPS for the current year.

Globe Life Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. Globe Life's payout ratio is 8.76%.

Globe Life declared that its Board of Directors has initiated a share buyback program on Monday, August 10th that authorizes the company to buyback $2.50 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 17.7% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's management believes its stock is undervalued.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source